- Home
- FCCO vs CVRX Comparison
FCCO vs CVRX Comparison
Compare FCCO & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FCCO | CVRX |
|---|---|---|
| Founded | 1994 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.9M | 253.2M |
| IPO Year | 1998 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FCCO | CVRX |
|---|---|---|
| Price | $29.36 | $9.03 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $30.00 | $13.17 |
| AVG Volume (30 Days) | 21.6K | ★ 232.9K |
| Earning Date | 01-21-2026 | 11-05-2025 |
| Dividend Yield | ★ 2.18% | N/A |
| EPS Growth | ★ 42.01 | N/A |
| EPS | ★ 2.40 | N/A |
| Revenue | ★ $74,180,000.00 | $55,969,000.00 |
| Revenue This Year | $23.03 | $11.49 |
| Revenue Next Year | $27.07 | $16.26 |
| P/E Ratio | $12.24 | ★ N/A |
| Revenue Growth | 18.23 | ★ 18.44 |
| 52 Week Low | $19.46 | $4.30 |
| 52 Week High | $29.57 | $18.55 |
Technical Indicators
Market Signals| Indicator | FCCO | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 64.57 | 43.50 |
| Support Level | $28.66 | $8.82 |
| Resistance Level | $29.40 | $9.63 |
| Average True Range (ATR) | 0.61 | 0.67 |
| MACD | 0.14 | -0.07 |
| Stochastic Oscillator | 88.89 | 34.29 |
Price Performance
Historical ComparisonAbout FCCO First Community Corporation
First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are; Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.